Etiology and oncogenesis of pancreatic carcinoma;Etiologija i onkogeneza karcinoma gušterače

Collegium Antropologicum

Volumn 36, Issue 3, 2012, Pages 1063-1067

  Dobrila Dintinjana, Renata ^a   Vanis, Nenad ^b   Dintinjana, Marijan ^c   Radić, Mladen ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KLINICKI CENTAR UNIVERZITETA U SARAJEVU   (Bosnia and Herzegovina)

^c General medicine practice Dr Marijan Dintinjan Office   (Croatia)

Author keywords

Etiology; Hereditary factors; Hereditary neoplastic syndromes; Oncogenesis; Pancreas; Pancreatic carcinoma

Indexed keywords

ADENOCARCINOMA; ARTICLE; GENETIC PREDISPOSITION; GENETICS; HEALTH; HUMAN; MORTALITY; ONCOGENE; PANCREAS TUMOR; RISK FACTOR;

ADENOCARCINOMA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ONCOGENES; PANCREATIC NEOPLASMS; RISK FACTORS; WORLD HEALTH;

EID: 84869806375     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. MAISONNEUVE P, LOWENFELS AB, Dig Disease, 28 (2010) 234. DOI:10.1159/000320068.
2. THOMAS DB, KARAGAS MR, Cancer Res, 47 (1987)5771.
3. RIES LAG, MELBERT D, KRAPCHO M, STINCHCOMB DG, HOWLADER N, HORNER MJ, National Cancer Institute, Bethesda, MD.
4. HENDRIX MJC, SEFTOR EA, Nature Reviews Cancer, 3 (2003) 411. DOI: 10.1038/nrc1092.
5. TERSMETTE AC, PETERSEN GM, OFFERHAUS GJ, Clin Cancer Res, 3 (2001) 738.
6. SCHNEIDER G, SCHMID RM, Mol Cancer, 2 (2003) 15. DOI: 10.1186/1476-4598-2-15.
7. HAMACHER R, SCHMID RM, SAUR D, SCHNEIDER G, Mol Cancer, 7 (2008) 64. DOI: 10.1186/1476-4598-7-64.
8. BLACKFORD A, SERRANO OK, WOLFGANG CL, PARMIGIANI G, JONES S, ZHANG X, PARSONS DW, Clin Cancer Res, 15 (2009) 4674. DOI: 10.1158/1078-0432.CCR-09-0227.
9. BÜCHLER P, REBER HA, BÜCHLER MW, FRIESS H, HINES OJ, Ann Surg, 236 (2002) 738. DOI: 10.1097/00000658-200212000-00006.
10. PETERSEN GM, AMUNDADOTTIR L, FUCHS CS, KRAFT P, Stolzenberg-Solomon RZ, JACOBS KB, Nature Genet, 42 (2010) 224. DOI: 10.1038/ng.522.
11. MAISONNEUVE P, MARSHALL BC, LOWENFELS AB, Gut, 56 (2007) 1327. DOI: 10.1136/gut.2007.125278
12. MACK TM, YU MC, HANISCH R, HENDERSON BE, J Natl Cancer Inst, 76 (1986) 49.
13. SHAPIRO JA, JACOBS EJ, THUN MJ, J Natl Cancer Inst, 92 (2000) 333. DOI: 10.1093/jnci/92.4.333.
14. STEVENS RJ, RODDAM AW, BERAL V, Br J Cancer, 96 (2007)507. DOI: 10.1038/sj.bjc.6603571.
15. CALLE EE, RODRIGUEZ C, Walker-Thurmond K, THUN MJ, N Engl J Med, 348 (2003)1625. DOI:10.1056/NEJMoa021423.
16. RISCH HA, J Natl Cancer Inst, 95 (2003) 948. DOI:10.1093/jnci/95.13.948.
17. LOWENFELS AB, MAISONNEUVE P, CAVALLINI G, AMMANN RW, LANKISCH PG, Int J Cancer, 328 (1993) 1433. DOI: 10.1002/ijc.20800.
18. LOWENFELS AB, MAISONNEUVE P, CAVALLINI G, N Engl J Med, (1993) 328. DOI:10.1056/NEJM199305203282001.
19. TAVANI A, LA VECCHIA C, Eur J Cancer Prev, 9 (2000) 241.
20. ZULLO A, FERREIRA PR, ERTEKIN MV, ZHAN CD (2000-2004)
21. LARSSON SC, HÅKANSSON N, GIOVANNUCCI E, WOLK A. J Natl Cancer Institute, 98 (2006) 407. DOI: 10.1093/jnci/djj094.
22. OJAJÄRVI A, PARTANEN T, AHLBOM A, BOFFETTA P, HAKULINEN T, Am J Epid, 153 (2001) 841. DOI: 10.1093/aje/153.9.841